Intelligent Topical Hair Growth System

Publication ID: 24-11857556_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Topical Hair Growth System,” Published Technical Disclosure No. 24-11857556_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857556_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,556.

Summary of the Inventive Concept

The present invention integrates topical dutasteride compositions with advanced technologies such as AI, IoT, blockchain, and nanomaterials to create a synergistic system for personalized hair growth treatment, monitoring, and optimization.

Background and Problem Solved

The original patent disclosed topical compositions of dutasteride for preventing hair loss and stimulating hair growth. However, these compositions lacked the ability to monitor treatment efficacy, personalize dosage, and ensure secure data storage. The present invention addresses these limitations by incorporating blockchain-based tracking, AI-driven hair loss analysis, IoT-enabled dosage tracking, and nanomaterial-based delivery systems.

Detailed Description of the Inventive Concept

The inventive concept comprises a topical composition of dutasteride, which is integrated with a blockchain-based tracking mechanism to monitor treatment efficacy and ensure secure data storage. The system further includes an AI-driven hair loss analysis module, which provides personalized treatment recommendations based on individual hair loss patterns. Additionally, an IoT-enabled dosage tracking device ensures accurate and timely application of the topical composition. In some embodiments, the topical composition may also include a penetration enhancer and a nanomaterial-based delivery system for enhanced bioavailability.

Novelty and Inventive Step

The integration of blockchain, AI, IoT, and nanomaterials with topical dutasteride compositions is novel and non-obvious compared to the original patent. The synergistic combination of these technologies enables a more effective, personalized, and secure hair growth treatment system.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, IoT devices, or nanomaterials. Variations of the system may also include the integration of additional technologies, such as augmented reality or 3D printing, to further enhance the hair growth treatment experience.

Potential Commercial Applications and Market

The Intelligent Topical Hair Growth System has significant commercial potential in the hair care industry, particularly in the areas of personalized hair growth treatment and monitoring. The system may be marketed to dermatologists, hair loss clinics, and individual consumers seeking advanced hair growth solutions.

Field of Art

Pharmaceutical formulations, topical drug delivery systems, and medical technology with a focus on hair loss treatments and digital health technologies

Person of Ordinary Skill (PHOSITA) Profile

A professional with expertise in pharmaceutical sciences, formulation chemistry, dermatology, and emerging digital health technologies, holding advanced degrees and practical experience in drug delivery and personalized medical treatments

Obviousness Rationale

A person having ordinary skill in the art would recognize that integrating digital tracking and personalization technologies with established topical pharmaceutical compositions represents a predictable extension of existing medical treatment paradigms. The source patent's topical dutasteride composition provides a clear foundation for technological augmentation through known digital health approaches. The proposed variations represent logical combinations of known techniques in pharmaceutical delivery and digital monitoring systems.

Obvious Combinations & Variations

Source Patent Element
Topical composition of dutasteride for hair loss treatment
PTD Variation
Adding nanomaterial-based delivery system for enhanced bioavailability
Obviousness Reasoning
Nanomaterial drug delivery is a well-established technique for improving pharmaceutical absorption, and a PHOSITA would recognize the predictable benefit of enhanced drug penetration in topical formulations
Source Patent Element
Topical hair loss treatment composition
PTD Variation
Integrating AI-driven personalized treatment recommendation system
Obviousness Reasoning
Machine learning algorithms for personalized medical treatment are increasingly common, and applying such techniques to existing pharmaceutical protocols represents an obvious design choice for improving patient outcomes
Source Patent Element
Topical dutasteride composition
PTD Variation
Blockchain-based tracking mechanism for monitoring treatment efficacy
Obviousness Reasoning
Secure digital tracking of medical treatments is a known technique in digital health, and extending such monitoring to pharmaceutical interventions would be an obvious technological progression
Source Patent Element
Hair loss treatment composition
PTD Variation
IoT-enabled dosage tracking device for ensuring accurate application
Obviousness Reasoning
Internet of Things technologies for medical adherence monitoring are well-established, and applying such tracking to topical pharmaceutical treatments represents a predictable technological integration
Source Patent Element
Topical pharmaceutical composition
PTD Variation
Adding penetration enhancers to improve drug delivery
Obviousness Reasoning
Penetration enhancers are a known technique in pharmaceutical formulation for improving drug absorption, and their application to existing topical compositions would be considered an obvious optimization by a skilled practitioner
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857556 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed combinations of topical dutasteride compositions with digital health technologies to be obvious extensions of existing pharmaceutical and technological knowledge. The integration of AI, blockchain, IoT, and nanomaterial delivery systems represents predictable technological progressions that would be readily conceived by a skilled practitioner seeking to enhance medical treatment monitoring and efficacy.

Original Patent Information

Patent NumberUS 11,857,556
TitleTopical compositions of dutasteride
Assignee(s)SHILPA MEDICARE LIMITED